Concord Biotech Market Cap ($1.49B USD)
Concord Biotech Market Cap ($1.49B USD). As of Oct. 22, 2026, Concord Biotech (CONCORDBIO) market capitalisation is ₹13451.55 Cr ($1.49B), with 10.59 Cr shares outstanding at a current price of ₹1270.70 on NSE, ranking 485 out of 5367 companies by market cap in our screener. Concord Biotech operates in the Healthcare sector and is classified as a Mid Cap stock. Examine CONCORDBIO Q4 results for recent quarterly revenue, profit and EPS trends.
Market Cap History of Concord Biotech (Last 10 Years)
CONCORDBIO market capitalisation from year-end NSE closing prices over the last 10 years. Compare with CONCORDBIO DCF valuation to assess whether the stock is under or overvalued.
End of Year Market Cap History — Concord Biotech
CONCORDBIO year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see Concord Biotech share price screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹13451.55 Cr
$1.49B USD
|
₹1270.70 | NSE | -5.57% |
| 2025 |
₹14244.44 Cr
$1.58B USD
|
₹1345.60 | NSE | -39.13% |
| 2024 |
₹23402.86 Cr
$2.60B USD
|
₹2210.75 | NSE | +50.21% |
| 2023 |
₹15580.38 Cr
$1.73B USD
|
₹1471.80 | NSE | - |